Magyar Verziˇ

Health-economic analyses

The Hungarian system of reimbursement demands a complex health-economic analysis in the case of some products. Our company has been dealing with the preparation of such analyses since 2004. We have handed in more than 50 applications, most of which were included in the positive list.

We prepare all the main types of complete analysis:

  • Cost-effectiveness analysis
  • Cost-minimisation analysis
  • Cost-utility analysis
  • Cost-benefit analysis

Cost-effectiveness analysis

In the case of cost effectiveness we measure results in some natural biological unit, while we measure costs in a currency.(e. g. how much one year of survival costs)

Cost-minimisation analysis

In the case of cost minimisation, we work with coinciding efficacy data. We investigate the different costs of reaching the same efficacy (e.g. decrease in blood pressure) in the case of one pharmaceutical and another.

Cost-utility analysis

In the case of cost-utility, we, most of the times, measure health-gain in QALY (quality-adjusted-life-years). Since the value can be determined for all technologies, different therapeutic areas become comparable.(e.g. dialysis to oncological therapy)

Cost-benefit analysis

In cost-benefit analysis we measure health-gain and costs in a given currency. So it enables us to compare the benefit of PET CT even to the benefit of building a kilometre of highway.

Cost-effectiveness analysis

In the case of cost effectiveness we measure results in some natural biological unit, while we measure costs in a currency.

Cost-minimisation analysis

In the case of cost-minimalization we work with coinciding efficacy data.

Cost-utility analysis

In the case of cost-utility, we most of the times measure health-gain in QALY (quality-adjusted-life-years).

Cost benefit analysis

In cost-benefit analysis we measure health-gain and costs in a given currency.

Partners: